ASK1-JNK3 signaling pathway plays a key role in the pathogenesis of Parkinson’s disease (PD), and activated JNK3 can induce apoptosis by phosphorylating a variety of target proteins [34], so both ASK1 and JNK3 are potential targets for the development of PD treatment. Here, MAP3K5 is linked to Parkinson disease.